- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Wall Street JournalEN
O
OCX
Oncocyte Corporation
3.20
0.47+17.22%After Hours: 3.240 +0.040 +1.25%18:34 06/17 EDT
OPEN/PREV CLOSE2.770/2.730
TODAY RANGE2.710-3.210
VOL100.56K
MARKET CAP91.52M
52 WEEK RANGE1.922-4.750
AVG VOL (3M)44.64K
% TURNOVER0.35%
TURNOVER--
P/E (TTM)-0.9079
% RANGE17.95%
EPS(TTM)-3.5245
P/E(FORWARD)-3.2990
P/B8.96
BVPS0.3573
DIVIDEND--
P/S29.68
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP71.35M
SHARES OUTSTANDING28.60M
NEXT EARNINGS08/06-08/11
FREE FLOAT22.30M
LOT SIZE1
EX-DATE07/25/2023
News
Press Releases
Financial Reports
Profile
TipRanks·10h ago
Lake Street Keeps Their Buy Rating on OncoCyte (OCX)
TipRanks·11h ago
OncoCyte Rebrands to Insight Molecular Diagnostics
TipRanks·11h ago
OncoCyte changes name to Insight Molecular Diagnostics
TipRanks·05/21 18:15
Needham medtech & diagnostics analyst holds analyst/industry conference call
Dow Jones·05/21 17:46
Oncocyte Is Maintained at Buy by Lake Street
Dow Jones·05/21 17:46
Oncocyte Price Target Raised to $8.00/Share From $5.00 by Lake Street
TipRanks·05/21 12:50
OncoCyte reports Medicare boosts reimbursement for GraftAssureCore
TipRanks·05/21 12:45
OncoCyte price target raised to $8 from $5 at Lake Street
TipRanks·05/16 02:00
OncoCyte Corp’s Earnings Call: Optimism Amid Challenges
TipRanks·05/13 12:49
Lake Street Remains a Buy on OncoCyte (OCX)
Dow Jones·05/13 12:02
Oncocyte Price Target Maintained With a $4.25/Share by Needham
Benzinga·05/13 11:52
Needham Reiterates Buy on OncoCyte, Maintains $4.25 Price Target
TipRanks·05/13 04:19
OncoCyte Corp Reports Revenue Growth Amid Losses
Same Industry
Name/Symbol
Change%
Price